Curated News
By: NewsRamp Editorial Staff
September 06, 2024

Syntekabio to Showcase AI-Driven Discovery Solutions at BioTechX USA

Reddit Discuss on RedditDiscuss on LinkedIn LinkedInView History of this news story on GitHub Github
Source News Release

TLDR

  • Syntekabio is the Title Sponsor and will give a keynote address at BioTechX USA, positioning itself as a leader in AI-driven drug development.
  • Syntekabio's AI-driven technologies enable pharmaceutical and biotech companies to test the validity of target proteins without upfront costs, followed by STB LaunchPad program for delivering validated results.
  • Syntekabio's AI-driven solutions improve and accelerate R&D activities, offering potential hits and optimized leads in drug discovery, antibody prediction, and cancer neoantigen discovery to develop novel and effective therapeutics.
  • Syntekabio's participation at BioTechX USA includes a keynote presentation on addressing data scarcity in drug discovery with AI models, and a session on flexible molecular docking for neoantigen and antibody drug prediction.

Impact - Why it Matters

This news matters because it highlights the cutting-edge AI-driven solutions offered by Syntekabio, which could revolutionize the drug discovery process. The 'Develop Now, Pay Later' offer and in silico biologics platforms provide valuable tools for pharmaceutical and biotechnology companies, potentially accelerating the development of novel and effective therapeutics.

Summary

Syntekabio (KOSDAQ: 226330), an artificial intelligence (AI) based drug development company, is the Title Sponsor at BioTechX USA, where they will discuss their AI-driven solutions and host a booth. They recently announced a 'Develop Now, Pay Later' offer, allowing clients to test the validity of a target protein without upfront costs. Syntekabio will also present their AI in drug discovery and highlight their in silico biologics platforms at the conference.

Source Statement

This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Syntekabio to Showcase AI-Driven Discovery Solutions at BioTechX USA

blockchain registration record for the source press release.